活体肝移植治疗重肝

上传人:小** 文档编号:47492908 上传时间:2018-07-02 格式:PDF 页数:7 大小:2.40MB
返回 下载 相关 举报
活体肝移植治疗重肝_第1页
第1页 / 共7页
活体肝移植治疗重肝_第2页
第2页 / 共7页
活体肝移植治疗重肝_第3页
第3页 / 共7页
活体肝移植治疗重肝_第4页
第4页 / 共7页
活体肝移植治疗重肝_第5页
第5页 / 共7页
点击查看更多>>
资源描述

《活体肝移植治疗重肝》由会员分享,可在线阅读,更多相关《活体肝移植治疗重肝(7页珍藏版)》请在金锄头文库上搜索。

1、LiverHepato-Gastroenterology 2011; 58:1-6 H.G.E. Update Medical Publishing S.A., Athens-StuttgartA Single Institution Experience with Living Donor Liver Transplantation for Acute-on-chronic Hepatitis B Liver FailureBackground/Aims: This study reports our pre- liminary experience of living donor live

2、r transplan- tation (LDLT) for patients with acute-on-chronic liver failure (AoCLF) caused by hepatitis B. Methodology: 47 patients who demonstrated Ao- CLF caused by hepatitis B with mean (SD) Mod- el for End-Stage Liver Disease scores of 39.25.1 were divided by the transplantation group (n=19) and

3、 the non-transplantation group (n=28) accord- ing to whether or not undergoing LDLT. At the same time, 30 hepatitis B cirrhosis recipients who underwent LDLT and did not reach the criteria of AoCLF were selected as the control group (n=30). In the transplantation group, veno-venous by- pass, molecul

4、ar adsorbent recirculating system (MARS) and continuous renal replacement ther- apy (CRRT) were introduced. The intraoperative data, post-transplant complications and mortality were analyzed retrospectively. Results: There were no significant differences in survival rates of 1, 6 and 12 months and t

5、he postoperative complications except for pneumo- nia and diabetes, between the control group and the transplantation group (p0.05). Recurrence of hepatitis B was not found in the recipients of the control group and the transplantation group. Conclusion: Right-lobe LDLT may be an effec- tive therape

6、utic option for patients with acute-on- chronic hepatitis B liver failure.ABSTRACTINTRODUCTIONIn the USA, the most frequent underlying cause for acute-on-chronic liver failure (AoCLF) is irre- versible liver damage due to chronic alcohol abuse, followed by viral hepatitis and autoimmune disor- ders

7、(1), but in China, type B hepatitis is the most common cause (2). Despite recent technological advances AoCLF remains a clinical condition as- sociated with high mortality unless urgent ortho- topic liver transplantation (OLT) is performed on time, which is due to acute decompensation of liver funct

8、ion in patients with chronic pre-existing liver diseases (3,4). The shortage of cadaveric livers has sparked an interest in adult-to-adult living donor liver transplantation (LDLT). LDLT with right lobe grafts has dramatically increased with the increas- ing success rates and lower donor morbidities

9、 (5,6). At present, right-lobe LDLT is adopted as one of the solutions to overcome the graft shortage in adult patients waiting for liver transplantation (5,6). The survival results of patients demonstrating AoCLF and undergoing LDLT have been reported to be poor (7). However, in our center, a bette

10、r result of LDLT for patients with AoCLF has been achieved. There- fore, our preliminary experience of LDLT treatment for AoCLF is reported in this manuscript.METHODOLOGY From January 2002 to November 2007, 138 LD- LTs, including 12 pediatric (less than 18 years of age) and 126 adult cases were perf

11、ormed in West China Hospital, Sichuan University. The 126 adult- to-adult LDLTs consisted of 125 cases using right lobe graft without middle hepatic vein (MHV), and 7 cases using dual grafts (1 case using 2 left lobes, 6 using 1 right lobe without MHV and 1 left lobe). The most common indications fo

12、r adult-to-adult LDLT in our center were liver cirrhosis caused by hepatitis B virus, primary liver cancer. The selec- tion criteria for AoCLF caused by hepatitis B in this group were: chronic pre-existing hepatitis B, serum bilirubin 280mol/L (20mg/dL) and/or hepatic en- cephalopathy grade 2 (8,9).

13、 According to the above criteria, 19 recipients who underwent LDLT and accorded with acute-on-Zheyu Chen1, TianFu Wen1, Yong Zeng1, Lichun Wang2, Jia jie Lu2, Shu Gong1, Hong Tan2, Ping Feng2, Bo Li1, JiChun Zhao1, WenTao Wang1, MingQing Xu1, Jiayin Yang1, Hong Wu1 and LuNan Yan11Liver Transplantati

14、on Center and Hepato-Bilio-Pancreatology Department, West China Hospital, West China Medical School of Sichuan University, Chengdu, China 2Infectious Disease Center, West China Medical School of Sichuan University, Chengdu, ChinaCorresponding author: LuNan Yan, Liver Transplantation Center and Hepat

15、o-Bilio-Pancreatology Department, West China Hospital, West China Medical School of Sichuan University, Chengdu, 610041, China E-mail: KEY WORDS: Acute-on-chronic liver failure; Mo- lecular adsorbent re-circulating system; Living donor liver trans- plantation; Continuous renal replacement therapyHep

16、ato-Gastroenterology 58 (0)Z Chen, T Wen, Y Zeng, et al.chronic hepatitis B liver failure were selected as the transplantation group in this manuscript. The 28 recipients who did not undergo LDLT owing to the shortage of donors and registered in our center and accorded with acute-on-chronic hepatitis B liver failure were selected as the non-transplantation group. At the same time, 30 hepatitis

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 商业/管理/HR > 经营企划

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号